John R Apps,Gabriela Carreno,Jose Mario Gonzalez-Meljem,Scott Haston,Romain Guiho,Julie E Cooper,Saba Manshaei,Nital Jani,Annett Hölsken,Benedetta Pettorini,Robert J Beynon,Deborah M Simpson,Helen C Fraser,Ying Hong,Shirleen Hallang,Thomas J Stone,Alex Virasami,Andrew M Donson,David Jones,Kristian Aquilina,Helen Spoudeas,Abhijit R Joshi,Richard Grundy,Lisa C D Storer,Márta Korbonits,David A Hilton,Kyoko Tossell,Selvam Thavaraj,Mark A Ungless,Jesus Gil,Rolf Buslei,Todd Hankinson,Darren Hargrave,Colin Goding,Cynthia L Andoniadou,Paul Brogan,Thomas S Jacques,Hywel J Williams,Juan Pedro Martinez-Barbera

Abstract:Adamantinomatous craniopharyngiomas (ACPs) are clinically challenging tumours, the majority of which have activating mutations in CTNNB1. They are histologically complex, showing cystic and solid components, the latter comprised of different morphological cell types (e.g. β-catenin-accumulating cluster cells and palisading epithelium), surrounded by a florid glial reaction with immune cells. Here, we have carried out RNA sequencing on 18 ACP samples and integrated these data with an existing ACP transcriptomic dataset. No studies so far have examined the patterns of gene expression within the different cellular compartments of the tumour. To achieve this goal, we have combined laser capture microdissection with computational analyses to reveal groups of genes that are associated with either epithelial tumour cells (clusters and palisading epithelium), glial tissue or immune infiltrate. We use these human ACP molecular signatures and RNA-Seq data from two ACP mouse models to reveal that cell clusters are molecularly analogous to the enamel knot, a critical signalling centre controlling normal tooth morphogenesis. Supporting this finding, we show that human cluster cells express high levels of several members of the FGF, TGFB and BMP families of secreted factors, which signal to neighbouring cells as evidenced by immunostaining against the phosphorylated proteins pERK1/2, pSMAD3 and pSMAD1/5/9 in both human and mouse ACP. We reveal that inhibiting the MAPK/ERK pathway with trametinib, a clinically approved MEK inhibitor, results in reduced proliferation and increased apoptosis in explant cultures of human and mouse ACP. Finally, we analyse a prominent molecular signature in the glial reactive tissue to characterise the inflammatory microenvironment and uncover the activation of inflammasomes in human ACP. We validate these results by immunostaining against immune cell markers, cytokine ELISA and proteome analysis in both solid tumour and cystic fluid from ACP patients. Our data support a new molecular paradigm for understanding ACP tumorigenesis as an aberrant mimic of natural tooth development and opens new therapeutic opportunities by revealing the activation of the MAPK/ERK and inflammasome pathways in human ACP.

Epigenetic Control of Adamantinomatous Craniopharyngiomas

Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target

Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma

RARE-29. Transcriptome characterization of pediatric adamantinomatous craniopharyngioma at the cellular level

Multiomics integration-based immunological characterizations of adamantinomatous craniopharyngioma in relation to keratinization

Molecular Cluster Mining of Adrenocortical Carcinoma Via Multi-Omics Data Analysis Aids Precise Clinical Therapy.

Integrative Analysis of Biomarkers and Mechanisms in Adamantinomatous Craniopharyngioma

Unraveling the Complexity of the Senescence-Associated Secretory Phenotype in Adamantinomatous Craniopharyngioma Using Multi-Modal Machine Learning Analysis

Single-cell and spatial sequencing identifies senescent and germinal tumor cells in adamantinomatous craniopharyngiomas

Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression

Bioinformatics analysis and validation of the critical genes associated with adamantinomatous craniopharyngioma

DNA methylation signature is prognostic of choroid plexus tumor aggressiveness

MMP12 is a Potential Therapeutic Target for Adamantinomatous Craniopharyngioma: Conclusions from Bioinformatics Analysis and in Vitro Experiments.

Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: based on single nucleus RNA-Seq and spatial transcriptome profiling.

Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas

Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma

The Inflammatory Milieu of Adamantinomatous Craniopharyngioma and Its Implications for Treatment

High Expression Levels of CXCL12 and CXCR4 Predict Recurrence of Adamanti-Nomatous Craniopharyngiomas in Children

Genome-Wide DNA Methylation Profiling as a Prognostic Marker in Pituitary Adenomas—A Pilot Study

Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations

Advances in the treatment of Adamantinomatous craniopharyngioma: How to balance tumor control and quality of life in the current environment: a narrative review